Financhill
Sell
10

BTAI Quote, Financials, Valuation and Earnings

Last price:
$1.64
Seasonality move :
-1.49%
Day range:
$1.53 - $1.73
52-week range:
$1.53 - $49.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.82x
P/B ratio:
--
Volume:
242.5K
Avg. volume:
9.2M
1-year change:
-96.21%
Market cap:
$8.9M
Revenue:
$2.3M
EPS (TTM):
-$2.16

Earnings Data

Next earnings date for BTAI
May 09
2025
Most recent earnings per share
-$3.57
Beat by $1.57
(Mar 27/2025)
Consensus Estimate
-$5.14
(Mar 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BTAI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $400K -- -- -$2.16 --
05/09/2025 Q1 $350K -- -- -$3.04 --
03/27/2025 Q4 $718.3K $366K -$3.57 -$5.14 $1.57
11/14/2024 Q3 $1.3M $214K -$5.12 -$7.68 $2.56
08/06/2024 Q2 $1.1M $1.1M -$3.36 -$10.99 $7.63
05/09/2024 Q1 $632.6K $582K -$13.92 -$11.52 -$2.40
03/12/2024 Q4 $741.3K $376K -$12.16 -$12.72 $0.56
11/14/2023 Q3 $626K $341K -$27.52 -$20.00 -$7.52
08/14/2023 Q2 $466.9K $457K -$29.28 -$27.68 -$1.60
05/08/2023 Q1 $323.8K $206K -$29.44 -$25.37 -$4.07
03/09/2023 Q4 $1.1M $238K -$31.20 -$22.61 -$8.59
11/10/2022 Q3 -- $137K -$23.84 -- --
08/09/2022 Q2 -- -- -$21.60 -- --
05/09/2022 Q1 -- -- -$17.92 -- --
03/10/2022 Q4 -- -- -$14.88 -- --
11/10/2021 Q3 -- -- -$15.36 -- --
08/10/2021 Q2 -- -- -$17.76 -- --
05/10/2021 Q1 -- -- -$17.28 -- --
03/11/2021 Q4 -- -- -$13.92 -- --
11/12/2020 Q3 -- -- -$17.12 -- --
08/14/2020 Q2 -- -- -$16.96 -- --
05/12/2020 Q1 -- -- -$12.64 -- --
03/09/2020 Q4 -- -- -$7.20 -- --
11/14/2019 Q3 -- -- -$9.12 -- --
08/06/2019 Q2 -- -- -$8.64 -- --
05/07/2019 Q1 -- -- -$7.36 -- --
03/07/2019 Q4 -- -- -$7.36 -- --
11/09/2018 Q3 -- -- -$4.96 -- --
08/08/2018 Q2 -- -- -$3.04 -- --
05/14/2018 Q1 -- -- -$5.92 -- --
12/31/2017 Q4 -- -- -$2.66 -- --
09/30/2017 Q3 -- -- -$0.94 -- --
06/30/2017 Q2 -- -- -$0.58 -- --
03/31/2017 Q1 -- -- -$0.54 -- --

BioXcel Therapeutics Earnings Questions

  • How Much did BioXcel Therapeutics Generate in Revenue Last Quarter?

    BioXcel Therapeutics reported $366K worth of top line sales in its most recent quarter.

  • Did BioXcel Therapeutics Beat Earnings Last Quarter?

    BioXcel Therapeutics announced earnings per share of -$3.57 which represents a beat of analyst forecast a -$5.14 per share.

  • Is BioXcel Therapeutics Profitable?

    BioXcel Therapeutics reported -$956K that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for BioXcel Therapeutics EPS Next Year?

    BioXcel Therapeutics's earnings are forecast to decrease from -$23.51 per share to -$23.27 per share next year representing a decrease of -1.02%.

  • When is BioXcel Therapeutics's Earnings Date?

    BioXcel Therapeutics's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock